Physician profile
Usama Assaad
NPI 1497097174
$5,824.21
in general payments reported to CMS, 2019-2025
35 companies · $1,121 in 2025
The $1,121 reported for 2025 was more than what a typical Pulmonary Disease provider received nationally (typical 2025 total: $500).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $602 · 2020: $47.70 · 2021: $291 · 2022: $1,381 · 2023: $1,340 · 2024: $1,040 · 2025: $1,121.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,616 · Travel and Lodging: $635 · Education: $250.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,616.34 |
| Travel and Lodging | $635.47 |
| Education | $250.20 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ethicon INC. | $970.38 | 2022 | |
| Glaxosmithkline, LLC. | $838.28 | 2019-2025 | Nucala, Trelegy Ellipta, Arexvy |
| Pulmonx Corporation | $772.78 | 2023 | Pulmonx Chartis Tablet Console, Zephyr Delivery Catheter, Zephyr Endobronchial Valve |
| Astrazeneca Pharmaceuticals LP | $464.93 | 2019-2025 | Airsupra, Fasenra, Tezspire |
| Regeneron Healthcare Solutions, INC. | $299.53 | 2023-2025 | Dupixent |
| Boehringer Ingelheim Pharmaceuticals, INC. | $237.22 | 2019-2025 | Jascayd |
| Genentech USA, INC. | $234.83 | 2019-2024 | Xolair |
| Grifols USA, LLC | $206.35 | 2022-2025 | Prolastin-C Liquid |
| Stryker Corporation | $196.83 | 2025 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Inspire Medical Systems, INC. | $193.08 | 2024 | Inspire |
| Genzyme Corporation | $168.27 | 2019-2025 | |
| Actelion Pharmaceuticals US, INC. | $135.99 | 2024 | Opsumit, Uptravi |
| Insmed, INC. | $135.15 | 2021-2025 | Arikayce |
| Electromed, INC. | $101.27 | 2022-2025 | Smartvest |
| Harmony Biosciences LLC | $86.40 | 2021-2025 |
Show all 35 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Takeda Pharmaceuticals U.S.A., INC. | $83.98 | 2023-2024 | Glassia |
| Sanofi-Aventis U.S. LLC | $78.99 | 2023 | |
| Mylan Specialty L.P. | $77.69 | 2021-2024 | Yupelri |
| United Therapeutics Corporation | $76.89 | 2024-2025 | Tyvaso, Tyvaso |
| 3b Medical, INC. | $67.38 | 2023 | Luna |
| Merck Sharp & Dohme LLC | $54.90 | 2023-2025 | Keytruda |
| Jazz Pharmaceuticals INC. | $49.67 | 2019 | |
| Baxter Healthcare | $48.04 | 2024 | Hillrom - Vest System Model 105 Home Care |
| Viatris Specialty LLC | $31.48 | 2025 | Yupelri |
| Lilly USA, LLC | $28.39 | 2025 | Zepbound |
| Inogen, INC. | $24.30 | 2023 | Inogen One G5 Oxygen Concentrator - Bluetooth |
| Verona Pharma, INC. | $22.50 | 2025 | Ohtuvayre |
| Resmed Corp | $21.85 | 2025 | |
| Zoll Respicardia, INC. | $21.31 | 2024 | Remede System |
| Circassia INC. | $18.70 | 2019 | |
| Shire North American Group INC | $18.46 | 2019 | |
| Melinta Therapeutics, LLC | $16.74 | 2021 | |
| Mallinckrodt Hospital Products INC. | $16.47 | 2020 | |
| Paratek Pharmaceuticals, INC. | $13.82 | 2021 | |
| Itamar Medical INC | $11.36 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Usama Assaad listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.